Neurocrine Biosciences reported $154.6M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 2.98B 99M
Acadia Pharmaceuticals ACAD:US $ 81.67M 15.12M
Acorda Therapeutics ACOR:US $ 29.62M 2.74M
Adamas Pharmaceuticals ADMS:US 29.73M 579K
Agios Pharmaceuticals AGIO:US $ 27.15M 2.06M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Alnylam Pharmaceuticals ALNY:US $ 142.07M 11.75M
Amgen AMGN:US $ 1.31B 79M
Aptinyx Inc APTX:US $ 4.93M 142K
Biogen BIIB:US $ 654.1M 16.8M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Cytokinetics CYTK:US $ 26.2M 5M
Dynavax Technologies DVAX:US $ 26.93M 5.85M
Exelixis EXEL:US $ 101.56M 3.06M
Gilead Sciences GILD:US $ 1.18B 173M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Halozyme Therapeutics HALO:US $ 13.17M 848K
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
Intra Cellular Therapies ITCI:US $ 70.5M 646.73K
Nektar Therapeutics NKTR:US $ 29.47M 87K
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Pfizer PFE:US $ 2.73B 61M
Prothena PRTA:US 11.96M 923K
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Repligen RGEN:US $ 49.97M 7.13M
Rigel Pharmaceuticals RIGL:US $ 22.88M 499K
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
Teva Pharmaceutical TEVA:IT 864M 32M
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M
Xoma XOMA:US $ 4.26M 328K
YTE INCY:US $ 190.7M 21.84M
Zogenix ZGNX:US $ 39.56M 5.68M